DSpace Repository

Synthesis and molecular docking of 1,2,3-triazole-based sulfonamides as aromatase inhibitors

Show simple item record

dc.contributor.author Pingaew R.
dc.contributor.author Prachayasittikul V.
dc.contributor.author Mandi P.
dc.contributor.author Nantasenamat C.
dc.contributor.author Prachayasittikul S.
dc.contributor.author Ruchirawat S.
dc.contributor.author Prachayasittikul V.
dc.date.accessioned 2021-04-05T03:26:28Z
dc.date.available 2021-04-05T03:26:28Z
dc.date.issued 2015
dc.identifier.issn 9680896
dc.identifier.other 2-s2.0-84937425435
dc.identifier.uri https://ir.swu.ac.th/jspui/handle/123456789/13782
dc.identifier.uri https://www.scopus.com/inward/record.uri?eid=2-s2.0-84937425435&doi=10.1016%2fj.bmc.2015.04.036&partnerID=40&md5=ded6150540b91998db68cccbfd84b0e8
dc.description.abstract Abstract A series of 1,4-disubstituted-1,2,3-triazoles (13-35) containing sulfonamide moiety were synthesized and evaluated for their aromatase inhibitory effects. Most triazoles with open-chain sulfonamide showed significant aromatase inhibitory activity (IC50 = 1.3-9.4 μM). Interestingly, the meta analog of triazole-benzene-sulfonamide (34) bearing 6,7-dimethoxy substituents on the isoquinoline ring displayed the most potent aromatase inhibitory activity (IC50 = 0.2 μM) without affecting normal cell. Molecular docking of these triazoles against aromatase revealed that the compounds could snugly occupy the active site of the enzyme through hydrophobic, π-π stacking, and hydrogen bonding interactions. The potent compound 34 was able to form hydrogen bonds with Met374 and Ser478 which were suggested to be the essential residues for the promising inhibition. The study provides compound 34 as a potential lead molecule of anti-aromatase agent for further development. © 2015 Elsevier Ltd.
dc.subject 1,2,3 triazole derivative
dc.subject 1,2,3 triazole sulfonamide derivative
dc.subject 4 [[1 [3 [(3,4 dihydroisoquinolin 2 (1h)yl)sulfonyl]phenyl] 1h 1,2,3 triazol 4 yl]methoxy] 2h chromen 2 one
dc.subject 4 [[1 [3 [(6,7 dimethoxy 3,4 dihydroisoquinolin 2 (1h)yl)sulfonyl]phenyl] 1h 1,2,3 triazol 4 yl]methoxy] 2h chromen 2 one
dc.subject 7 [[1 [3 [(3,4 dihydroisoquinolin 2 (1h)yl)sulfonyl]phenyl] 1h 1,2,3 triazol 4 yl]methoxy] 2h chromen 2 one
dc.subject 7 [[1 [3 [(6,7 dimethoxy 3,4 dihydroisoquinolin 2 (1h)yl)sulfonyl]phenyl] 1h 1,2,3 triazol 4 yl]methoxy] 2h chromen 2 one
dc.subject aromatase inhibitor
dc.subject coumarin oxymethyl
dc.subject functional group
dc.subject ketoconazole
dc.subject letrozole
dc.subject naphthalene oxymethyl
dc.subject phenoxymethyl
dc.subject phenyl group
dc.subject sulfonamide
dc.subject sulfonyl group
dc.subject unclassified drug
dc.subject antineoplastic agent
dc.subject aromatase
dc.subject aromatase inhibitor
dc.subject CYP19A1 protein, human
dc.subject isoquinoline derivative
dc.subject protein binding
dc.subject sulfonamide
dc.subject triazole derivative
dc.subject animal cell
dc.subject Article
dc.subject binding affinity
dc.subject binding site
dc.subject carbon nuclear magnetic resonance
dc.subject chemical interaction
dc.subject chemical reaction
dc.subject Click reaction
dc.subject concentration response
dc.subject controlled study
dc.subject drug cytotoxicity
dc.subject drug mechanism
dc.subject drug potency
dc.subject drug safety
dc.subject drug screening
dc.subject drug synthesis
dc.subject enzyme active site
dc.subject enzyme inhibition
dc.subject hydrogen bond
dc.subject hydrophobicity
dc.subject IC50
dc.subject mass spectrometry
dc.subject molecular docking
dc.subject nonhuman
dc.subject pi pi stacking interaction
dc.subject proton nuclear magnetic resonance
dc.subject structure activity relation
dc.subject Vero cell line
dc.subject animal
dc.subject cell survival
dc.subject chemical phenomena
dc.subject chemistry
dc.subject Chlorocebus aethiops
dc.subject drug effects
dc.subject human
dc.subject synthesis
dc.subject Animals
dc.subject Antineoplastic Agents
dc.subject Aromatase
dc.subject Aromatase Inhibitors
dc.subject Catalytic Domain
dc.subject Cell Survival
dc.subject Cercopithecus aethiops
dc.subject Humans
dc.subject Hydrogen Bonding
dc.subject Hydrophobic and Hydrophilic Interactions
dc.subject Isoquinolines
dc.subject Molecular Docking Simulation
dc.subject Protein Binding
dc.subject Structure-Activity Relationship
dc.subject Sulfonamides
dc.subject Triazoles
dc.subject Vero Cells
dc.title Synthesis and molecular docking of 1,2,3-triazole-based sulfonamides as aromatase inhibitors
dc.type Article
dc.rights.holder Scopus
dc.identifier.bibliograpycitation Bioorganic and Medicinal Chemistry. Vol 23, No.13 (2015), p.3472-3480
dc.identifier.doi 10.1016/j.bmc.2015.04.036


Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

Search DSpace


Advanced Search

Browse

My Account

Statistics